Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc

Registered Charity 3104


Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.


ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?

Is an enzyme called GAD responsible for Fibromyalgia?

Friday 24 June 2011's Adrienne Dellwo reports:


GABAIs an Enzyme Called GAD Responsible for Fibromyalgia?

By Adrienne Dellwo, Guide
June 22, 2011

Research Brief

A recently published hypothesis raises the possibility that an enzyme involved in type-1 diabetes may also be an underlying cause of fibromyalgia (FMS).

The enzyme is glutamic acid decarboxylase (GAD) -- specifically, a form called GAD65. It's primary job is to help turn a neurotransmitter (chemical messenger in the brain) called glutamate into another neurotransmitter called GABA. Glutamtate is an excitotoxin, meaning it gets areas of the brain over stimulated to potentially dangerous levels, while GABA calms the brain. Some research shows that FMS involves an imbalance of these two chemicals.

In the journal Medical Hypotheses, researchers lay out several reasons they believe problems with GAD levels or activity could play a critical role in this condition:

  1. Mice without GAD65 develop hyperalgesia, which is a key symptom of FMS;
  2. GAD plays a role in other disorders involving muscle stiffness and rigidity, similar to the morning stiffness common in FMS;
  3. GAD activity is decreased by stress, depression and anxiety, all of which are common in FMS;
  4. The poor deep sleep of FMS could hamper GAD activity in the brain;
  5. A component of GAD, called cofactor pyroxidine, is more likely to be low in women, and women are more likely to develop FMS;
  6. Obesity and sedentary lifestyle are risk factors for FMS, while low-calorie diets and exercise have been shown to increase both expression and activity of GAD.

The researchers are calling for studies looking at GAD expression and activity in FMS to see what role, if any, it might play.

Some interesting facts about GAD65 that weren't discussed in the paper also could lend support for the hypothesis.

GAD65 plays a role in type-1 (juvenile-onset) diabetes. Blood-sugar issues, including diabetes, are common in people with FMS (although the adult-onset form is most common.)

Additionally, the fibromyalgia drug Lyrica (pregabalin) is believed to increase GAD activity and therefore raise GABA levels. This is also true of the supplement valerian root, which is sometimes recommended for helping improve sleep in FMS.

GAD levels can be hampered by poor diet, tobacco use and alcohol, all of which have been shown to exacerbate FMS symptoms.

The researchers behind the hypothesis conclude that interventions -- both medicinal and behavioral -- aimed at altering or mimicking the effects of GAD could be effective for treating FMS.

Learn more or join the conversation!


Neurotransmitter Imbalance in Fibromyalgia
The Serotonin Series
Supplements by Symptom


The above, with comments, originally appeared here.



blog comments powered by Disqus
Previous Previous Page